Bioqual Inc
Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides contract research services in the areas of AIDS, influenza, respiratory syncytial virus, Coronavirus, malaria, hepatitis, cancer, and other infectious diseases, as well as flavivirus infections, including zika and dengue. It also offers small a… Read more
Bioqual Inc (BIOQ) - Total Liabilities
Latest total liabilities as of November 2025: $36.97 Million USD
Based on the latest financial reports, Bioqual Inc (BIOQ) has total liabilities worth $36.97 Million USD as of November 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Bioqual Inc - Total Liabilities Trend (1996–2025)
This chart illustrates how Bioqual Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Bioqual Inc Competitors by Total Liabilities
The table below lists competitors of Bioqual Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Coal Energy S.A.
WAR:CLE
|
Poland | zł3.50 Million |
|
TAFI Industries Bhd
KLSE:7211
|
Malaysia | RM256.92 Million |
|
FatPipe, Inc. Common Stock
NASDAQ:FATN
|
USA | $11.22 Million |
|
Lucent, Inc.
OTCQB:LUCN
|
USA | $102.69 Million |
|
US NeuroSurgical Holdings Inc
PINK:USNU
|
USA | $197.00K |
|
Harbor Bankshares Corporation
PINK:HRBK
|
USA | $238.94 Million |
|
HASS Corp
KQ:450330
|
Korea | ₩10.08 Billion |
|
Aplisens SA
WAR:APN
|
Poland | zł12.46 Million |
Liability Composition Analysis (1996–2025)
This chart breaks down Bioqual Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.41 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.03 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.51 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bioqual Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bioqual Inc (1996–2025)
The table below shows the annual total liabilities of Bioqual Inc from 1996 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-05-31 | $20.96 Million | +10.70% |
| 2024-05-31 | $18.94 Million | -20.10% |
| 2023-05-31 | $23.70 Million | -7.66% |
| 2022-05-31 | $25.67 Million | +29.06% |
| 2021-05-31 | $19.89 Million | -6.91% |
| 2020-05-31 | $21.37 Million | +470.44% |
| 2019-05-31 | $3.75 Million | -11.98% |
| 2018-05-31 | $4.26 Million | +10.68% |
| 2017-05-31 | $3.84 Million | -5.61% |
| 2016-05-31 | $4.07 Million | -10.95% |
| 2015-05-31 | $4.57 Million | +3.60% |
| 2014-05-31 | $4.42 Million | +204.99% |
| 2013-05-31 | $1.45 Million | -50.49% |
| 2011-05-31 | $2.92 Million | +41.25% |
| 2010-05-31 | $2.07 Million | -17.54% |
| 2007-05-31 | $2.51 Million | +23.02% |
| 2006-05-31 | $2.04 Million | -30.15% |
| 2005-05-31 | $2.92 Million | +38.07% |
| 2004-05-31 | $2.12 Million | +73.98% |
| 2003-05-31 | $1.22 Million | +16.37% |
| 2001-05-31 | $1.05 Million | -40.54% |
| 2000-05-31 | $1.76 Million | +55.89% |
| 1999-05-31 | $1.13 Million | +0.80% |
| 1998-05-31 | $1.12 Million | -19.31% |
| 1997-05-31 | $1.39 Million | +49.49% |
| 1996-05-31 | $927.39K | -- |